Plaque psoriasis is recognized as one of the most common types of psoriasis (an autoimmune disease that affects the skin and joints and manifests as red skin psoriatic, scaly patches called plaques). These patches are mostly in the skin of the elbows and knees, but can also affect areas like the scalp and genitals.
Plaque psoriasis is a chronic disease with an intensity ranging from patches to patches located throughout the body. It is not uncommon, even the fingers and toenails are not spared the brunt of this disease of the skin, which also can cause psoriatic arthritis (inflammation of the joints).
As for the causes of psoriasis remains a mystery to medicine, but most researchers believe that having a genetic factor. Psoriasis may be aggravated by factors such as stress, excessive alcohol drinking, smoking, etc.
Although there are a number of treatments, health professionals continue to face a challenge to treat psoriasis because of its recurrence. Although topical medications can be used to treat mild to moderate versions of this disease, severe manifestations (when it affects more than 10% of the body or prevents you from going about their daily activities) the demand for stronger action by oral retinoids as generic Soriatane.
What is Soriatane and for whom prescribed? Soriatane is an oral medication used to treat severe cases of plaque psoriasis, especially when all else has failed. Also known as acitretin, Soriatane is a synthetic (derived from laboratory) of vitamin A (also known as retinoic acid) and belongs to a class of medications called retinoids.
While large doses of vitamin A can reduce the thickness and scaling of the skin, excess doses of it can be toxic and may cause liver damage. Soriatane works by controlling the reproduction of skin cells, its speed growth and reduce inflammation. Soriatane also differs from other anti-psoriasis drugs that do not damage cells or act as a suppressor of immumo. By the way, Soriatane is the oral retinoid, which has only received approval from the FDA for the treatment of psoriasis.
During clinical trials and studies It has therefore been seen that a large majority of patients put on Soriatane showed marked improvement within 8 weeks.
Soriatane, however, is prohibits pregnant women, as another retinoid called Accutane was reported earlier to have caused birth defects in some newborns – the risk of miscarriage also appeared to be higher with this drug. Therefore, it is advisable for women of childbearing age to undergo two negative pregnancy tests before being administered Soriatane. They must also adopt two methods of birth control methods at least one month before beginning Soriatane treatment.
You should not take Soriatane if:
As for side effects, the use of Soriatane can cause dry skin and lips. Other conditions, though less frequent, are growth Abnormal bone, abnormal cholesterol and triglycerides as well as vision and problems.
Acitretin Therapy for Psoriasis